Avantor, Inc. (AVTR)

NYSE: AVTR · Real-Time Price · USD

11.85

+0.34 (2.95%)

At close: Nov 25, 2025, 4:00 PM EST

11.85

0.00 (0.00%)

After-hours: Nov 25, 2025, 7:30 PM EST

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2015 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2015 - 2020
Laboratory Solutions Revenue	4.41B	4.61B	Log In	Log In	Log In	Upgrade
Bioscience Production Revenue	2.17B	2.17B	Log In	Log In	Log In	Upgrade
Revenue (Total)	6.58B	6.78B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2015 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2015 - 2020
Americas Revenue	-	-	Log In	Log In	Log In	Upgrade
Europe Revenue	-	-	Log In	Log In	Log In	Upgrade
AMEA Revenue	-	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	6.58B	6.78B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2015 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2015 - 2020
Proprietary Materials & Consumables Revenue	-	-	Log In	Log In	Log In	Upgrade
Third Party Materials & Consumables Revenue	-	-	Log In	Log In	Log In	Upgrade
Services & Specialty Procurement Revenue	-	-	Log In	Log In	Log In	Upgrade
Equipment & Instrumentation Revenue	-	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	6.58B	6.78B	Log In	Log In	Log In	Upgrade

Adjusted EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2015 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2015 - 2020
Laboratory Solutions Adjusted Operating Income	543.30M	598.00M	Log In	Log In	Log In	Upgrade
Bioscience Production Adjusted Operating Income	540.00M	558.20M	Log In	Log In	Log In	Upgrade
Corporate Adjusted Operating Income	-71.60M	-66.40M	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-407.80M	-451.60M	Log In	Log In	Log In	Upgrade
Operating Income (Total)	603.90M	638.20M	Log In	Log In	Log In	Upgrade

Adjusted EBITDA by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2015 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2015 - 2020
Americas Adjusted EBITDA	-	-	Log In	Log In	Log In	Upgrade
Europe Adjusted EBITDA	-	-	Log In	Log In	Log In	Upgrade
AMEA Adjusted EBITDA	-	-	Log In	Log In	Log In	Upgrade
Corporate Adjusted EBITDA	-	-	Log In	Log In	Log In	Upgrade
Operating Income (Total)	603.90M	638.20M	Log In	Log In	Log In	Upgrade

Capital Expenditures by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2015 - 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2015 - 2020
Americas Capital Expenditures	-	Log In	Log In	Log In	Upgrade
Europe Capital Expenditures	-	Log In	Log In	Log In	Upgrade
AMEA Capital Expenditures	-	Log In	Log In	Log In	Upgrade

Updated Oct 29, 2025. Data Source: Fiscal.ai.